Phytoestrogens and indicators of breast cancer prognosis

Nutrition and Cancer

Volumn 56, Issue 1, 2006, Pages 3-10

  Ha, Tam C ^a,d   Lyons Wall, Philippa M ^c   Moore, Douglas E ^b   Tattam, Bruce N ^b   Boyages, John ^b   Ung, Owen A ^b   Taylor, Richard J ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; ISOFLAVONOID; LIGNAN; PHYTOESTROGEN; PROGESTERONE RECEPTOR; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CHINA; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; JAPAN; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; PHILIPPINES; PROGNOSIS; TUMOR VOLUME; UNITED STATES; BREAST TUMOR; CONFIDENCE INTERVAL; DIET; DRUG EFFECT; INCIDENCE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE; RISK; RISK FACTOR; SURVIVAL;

ADULT; AGED; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CONFIDENCE INTERVALS; DIET; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PHYTOESTROGENS; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; RECEPTORS, PROGESTERONE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33846637327     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5601_2     Document Type: Article

References (45)

1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2, 533-543, 2001.
2. Ajiki W and Yamamoto S: Cancer statistics digest. Breast cancer incidence for females in Japan. Jpn J Clin Oncol 29, 238, 1999.
3. Bray F, McCarron P, and Parkin DM: The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6, 229-239, 2004.
4. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, et al.: Migration patterns and breast cancer risk in Asian-American women. JNCI 85, 1819-1827, 1993.
5. Pisani P, Parkin DM, Bray F, and Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83, 18-29, 1999.
6. Wu AH, Ziegler RG, Nomura AM, West DW, Kolonel LN, et al.: Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr 68, S1437-S1443, 1998.
7. Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, et al.: Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 5, 901-906, 1996.
8. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, et al.: Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23, 1491-1496, 2002.
9. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, et al.: Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control 3, 313-322, 1992.
10. Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, et al.: Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8, 35-40, 1999.
11. Hirose K, Tajima K, Hamajima N, Inoue M, Takezaki T, et al.: A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 86, 146-154, 1995.
12. Yuan JM, Wang QS, Ross RK, Henderson BE, and Yu MC: Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71, 1353-1358, 1995.
13. Nagata C: Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int J Epidemiol 29, 832-836, 2000.
14. Ingram D, Sanders K, Kolybaba M, and Lopez D: Case-control study of phyto-oestrogens and breast cancer. Lancet 350, 990-994, 1997.
15. den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, et al.: Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 10, 223-228, 2001.
16. Miksicek RJ: Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 49, 153-160, 1994.
17. Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, et al.: Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49, 5111-5117, 1989.
18. Shao ZM, Alpaugh ML, Fontana JA, and Barsky SH: Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J Cell Biochem 69, 44-54, 1998.
19. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, et al.: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90, 2690-2694, 1993.
20. Shao ZM, Wu J, Shen ZZ, and Barsky SH: Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58, 4851-4857, 1998.
21. Boyapati SM, Shu X-O, Ruan ZX, Dai Q, Cai Q, et al.: Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study. Breast Cancer Res Treat 92, 11-17, 2005.
22. Ingram D: Diet and subsequent survival in women with breast cancer. Br J Cancer 69, 592-595, 1994.
23. Holmes MD, Stampfer MJ, Colditz GA, Rosner B, Hunter DJ, et al.: Dietary factors and the survival of women with breast carcinoma. Cancer 86, 826-835, 1999.
24. Saxe GA, Rock CL, Wicha MS, and Schottenfeld D: Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat 53, 241-253, 1999.
25. Taylor R, Davis P, and Boyages J: Long-term survival with breast cancer in New South Wales women. Eur J Cancer 39, 215-222, 2003.
26. Connolly JL, Boyages J, Nixon AJ, Peiro G, Gage I, et al.: Predictors of recurrence after conservative surgery and radiation therapy for invasive breast cancer. Mod Pathol 11, 134-139, 1998.
27. Pinder SE, Ellis IO, Galea M, O'Rouke S, Blamey RW, et al.: Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 24, 41-47, 1994.
28. Durnin JV and Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32, 77-97, 1974.
29. Smith W, Mitchell P, Reay EM, Webb K, and Harvey PW: Validity and reproducibility of a self-administered food frequency questionnaire in older people. ANZ J Pub Health 22, 456-463, 1998.
30. United States Department of Agriculture: USDA-Iowa State University Database on the Isoflavone Content of Foods, 1997.
31. Thompson LU, Robb P, Serraino M, and Cheung F: Mammalian lignan production from various foods. Nutr Cancer 16, 43-52, 1991.
32. Murphy PA, Song T, Buseman G, Barua K, Beecher GR, et al.: Isoflavones in retail and institutional soy foods. J Agric Food Chem 47, 2697-2704, 1999.
33. Chang B: Development and validation of a phytoestrogen questionnaire. In Masters of Nutrition and Dietetics Research Essays. Sydney: The University of Sydney, 1998.
34. Ha TC: Phytoestrogens and Indicators of Breast Cancer Survival. Sydney: The University of Sydney, 2004.
35. Karr SC, Lampe JW, Hutchins AM, and Slavin JL: Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am J Clin Nutr 66, 46-51, 1997.
36. D'Eredita G, Giardina C, Martellotta M, Natale T, and Ferrarese F: Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. Eur J Cancer 37, 591-596, 2001.
37. Vorgias G, Koukouras D, Paleogianni V, and Tzoracoeleftherakis E: Prognostic significance of factors affecting disease free interval and overall survival for stage II breast cancer in Greece. A multivariate cohort study. Eur J Obstet Gynecol Reprod Biol 95, 100-104, 2001.
38. Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, et al.: Pathological prognostic factors in breast cancer. IV. Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27, 219-226, 1995.
39. Hsieh CY, Santell RC, Haslam SZ, and Helferich WG: Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58, 3833-3838, 1998.
40. Constantinou AI, Krygier AE, and Mehta RR: Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice. Am J Clin Nutr 68, S1426-S1430, 1998.
41. Lamartiniere CA, Wang J, Smith-Johnson M, and Eltoum IE: Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol Sci 65, 228-238, 2002.
42. Murkies A, Dalais FS, Briganti EM, Burger HG, Healy DL, et al.: Phytoestrogens and breast cancer in postmenopausal women: a case control study. Menopause 7, 289-296, 2000.
43. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, and Tsugane S: Soy, isoflavones, and breast cancer risk in Japan. JNCI 95, 906-913, 2003.
44. Early Breast Cancer Trialists' Collaborative: Tamoxifen for early breast cancer. Cochrane Database Sys Rev CD000486, 2001.
45. Touillaud MS, Pillow PC, Jakovljevic J, Bondy ML, Singletary SE, et al.: Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer 51, 162-169, 2005.